Bisolvon Pentoxyverin 2.13 mg/ml, Sirup

7680697790014 CH-69779 Sirup

No image available

Article details

Package size
200 ml
Selling units
200
Measure
Flasche(n)
Galenic form
Sirup
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/12/2025
Patient information leaflet
Français
01/12/2025
Patient information leaflet
Italien
01/12/2025
Summary of Product Characteristics
Allemand
01/12/2025
Summary of Product Characteristics
Français
01/12/2025
Summary of Product Characteristics
Italien
01/12/2025

Detailed composition

Substance Quantity Type Category
pentoxyverini hydrogenocitras
2.13 MG Substance WIZUS
pentoxyverinum
1.35 MG Substance Wirkstoff (Principe actif)
acidum benzoicum
0.75 MG Substance HBESI
sorbitolum liquidum non cristallisabile
300.0 MG Substance HBESI
glycerolum (85 per centum)
- Substance HNIDK
propylenglycolum
100.0 MG Substance HBESI
acidum citricum monohydricum
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
saccharinum natricum
- Substance HNIDK
aromatica
- Substance AROMA
aromatica
- Substance AROMA
alcohol benzylicus
- Substance HBESI
ethanolum
- Substance HBESI
aqua purificata
- Substance HNIDK
natrium
0.393 MG Substance HBESI

Authorization holder

Opella Healthcare Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
69779
Drug name
Bisolvon Pentoxyverin, Sirup
Galenic form
SIRU
ATC Code
R05DB05
Authorization status
Z
Dispensing category
D
First authorization
21/08/2025
Authorization expiration date
20/08/2030
IT Number
03.01.2.
Domain
Human medicine
Field of application
Symptomatische Behandlung von unproduktivem (trockenem) Husten bei Erwachsenen, Jugendlichen und Kindern ab 6 Jahren

Package details

Description (FR)
BISOLVON Pentoxyverin 2.13 mg/ml siroup 2.13 mg 20
Description (DE)
BISOLVON Pentoxyverin 2.13 mg/ml Sirup 2.13 mg 200
Market launch
01/01/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data